Lv1
64 积分 2025-07-28 加入
Refractory high-risk mucous membrane pemphigoid treated with telitacicept
1天前
待确认
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
24天前
已完结
Interferon-induced senescent CD8+ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
1个月前
已完结
Interferon-induced senescent CD8+ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer
1个月前
已完结
IRF7 drives resistance to oncolytic virotherapy by restricting viral replication and suppressing antitumor immunity
1个月前
已完结
Metastatic behavior of breast cancer subtypes
1个月前
已完结
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
1个月前
已完结
Triple-negative breast cancer: clinical features and patterns of recurrence
1个月前
已完结
The "Cold Tumor" to "Hot Tumor" transformation strategy for triple-negative breast cancer: from mechanism to clinical translation
1个月前
已完结
CXCL8 induces M2 macrophage polarization and inhibits CD8+ T cell infiltration to generate an immunosuppressive microenvironment in colorectal cancer
1个月前
已完结
皖公网安备34019202002308
